Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.88 USD
Change Today -0.07 / -0.78%
Volume 227.3K
RDNT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:20 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

radnet inc (RDNT) Snapshot

Open
$8.95
Previous Close
$8.95
Day High
$9.03
Day Low
$8.80
52 Week High
11/6/14 - $10.35
52 Week Low
05/1/14 - $4.57
Market Cap
387.7M
Average Volume 10 Days
317.4K
EPS TTM
$0.31
Shares Outstanding
43.7M
EX-Date
--
P/E TM
28.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for RADNET INC (RDNT)

radnet inc (RDNT) Related Bloomberg News

View More Bloomberg News

radnet inc (RDNT) Related Businessweek News

No Related Businessweek News Found

radnet inc (RDNT) Details

RadNet, Inc. provides outpatient diagnostic imaging services in the United States. It offers various imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. The company also develops and sells computerized systems for the imaging industry, such as picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. As of December 31, 2014, it operated a network of 259 centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island, and New York. RadNet, Inc. was founded in 1985 and is headquartered in Los Angeles, California.

4,506 Employees
Last Reported Date: 03/16/15
Founded in 1985

radnet inc (RDNT) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $1.1M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $593.8K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $593.8K
Executive Vice President and General Counsel
Total Annual Compensation: $656.3K
Executive Vice President and Chief Operating ...
Total Annual Compensation: $593.8K
Compensation as of Fiscal Year 2013.

radnet inc (RDNT) Key Developments

Radnet, Inc. Announces Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

RadNet, Inc. announced consolidated unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total net revenue of $185,552,000 against $178,338, a year ago. Income from operations was $14,876,000 against $13,704,000 a year ago. Income before taxes was $7,173,000 against $4,092,000 a year ago. Net income attributable to company was $4,205,000 against $1,243,000 a year ago. Basic and diluted earnings per share were $0.10 against $0.03 a year ago. Adjusted EBITDA was $32,000,000 against $31,850,000 a year ago. Affecting net income in the fourth quarter of 2014 were certain non-cash expenses and non-recurring items including: $431,000 of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $265,000 of severance paid in connection with headcount reductions related to cost savings initiatives; $468,000 gain on the disposal of certain capital equipment; and $1.3 million of amortization of deferred financing fees and discount on issuance of debt related to existing credit facilities. For the year, the company reported total net revenue of $717,569,000 against $702,986,000 a year ago. Income from operations was $53,305,000 against $43,603,000 a year ago. Income before taxes was $3,652,000 against $5,886,000 a year ago. Net income attributable to company was $1,376,000 against $2,120,000 a year ago. Basic and diluted earnings per share were $0.03 against $0.05 a year ago. Net cash provided by operating activities was $61,004,000 against $66,422,000 a year ago. Purchase of imaging facilities was $9,428,000 against $7,223,000 a year ago. Purchase of property and equipment was $41,740,000 against $48,623,000 a year ago. Adjusted EBITDA was $126,513,000 against $112,843,000 a year ago. Excluding the loss on early extinguishment of senior notes from refinancing transaction, income before income taxes increased to $19.6 million for full-year 2014 from $5.9 million in 2013. Affecting net income in 2014 were certain non-cash expenses and non-recurring items including: $2.5 million of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $1.2 million of severance paid in connection with headcount reductions related to cost savings initiatives; $1.1 million loss on the disposal of certain capital equipment; and $5.7 million of amortization and write off of deferred financing fees and discount on issuance of debt related to existing credit facilities and refinancing transaction. The company announced that it is anticipating increased revenue, EBITDA and free cash flow for 2015. The company have significant growth drivers in plan, including benefiting from capitation contracts it signed in late 2014, revenue from recently announced breast disease management program in the nation of Qatar and continuing confidence about ability to drive same-center procedural volumes. Its refinancing transaction in March of last year will result in lower cash interest expense for 2015 and capital expenditures will be lower in 2015 than in 2014 (as 2014 included approximately $12 million of one-time spending related to the purchase of equipment it was previously renting). The combination of the lower cash interest expense and capital expenditures will increase free cash flow in 2015. The company expects revenue is to be in the range between from of $745 million to $765 million. Adjusted EBITDA is to be in the range between from of $123 million to $133 million. Capital expenditures are to be in the range between from of $40 million to $45 million. Cash interest expense is to be in the range between from of $34 million to $38 million. Free cash flow generation is to be in the range between from of $40 million to $50 million.

RadNet, Inc., Q4 2014 Earnings Call, Mar 16, 2015

RadNet, Inc., Q4 2014 Earnings Call, Mar 16, 2015

RadNet, Inc. Presents at Deutsche Bank Specialty Health Care Services 1x1 Day, Mar-18-2015

RadNet, Inc. Presents at Deutsche Bank Specialty Health Care Services 1x1 Day, Mar-18-2015 . Venue: JW Marriott Denver at Cherry Creek, 150 Clayton Lane, Denver, CO 80206, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDNT:US $8.88 USD -0.07

RDNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $22.47 USD -0.62
Enzo Biochem Inc $2.90 USD -0.11
Genomic Health Inc $29.55 USD -1.04
NeoGenomics Inc $4.61 USD -0.14
Otter Tail Corp $31.32 USD -0.18
View Industry Companies
 

Industry Analysis

RDNT

Industry Average

Valuation RDNT Industry Range
Price/Earnings 100.0x
Price/Sales 0.5x
Price/Book 71.5x
Price/Cash Flow 6.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RADNET INC, please visit www.radnet.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.